NO941073D0 - Phenylglycinamide of heterocyclic substituted phenylacetic acid derivatives - Google Patents

Phenylglycinamide of heterocyclic substituted phenylacetic acid derivatives

Info

Publication number
NO941073D0
NO941073D0 NO941073A NO941073A NO941073D0 NO 941073 D0 NO941073 D0 NO 941073D0 NO 941073 A NO941073 A NO 941073A NO 941073 A NO941073 A NO 941073A NO 941073 D0 NO941073 D0 NO 941073D0
Authority
NO
Norway
Prior art keywords
phenylglycinamide
acid derivatives
phenylacetic acid
heterocyclic substituted
substituted phenylacetic
Prior art date
Application number
NO941073A
Other languages
Norwegian (no)
Other versions
NO941073L (en
Inventor
Ulrich E Mueller
Juergen Dressel
Peter Fey
Rudolf Hanko
Walter Huebsch
Thomas Kraemer
Matthias Mueller-Gliemann
Martin Beuck
Stanislav Kazda
Stefan Wohlfeil
Andreas Knorr
Johannes-Peter Stasch
Siegfried Zaiss
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO941073D0 publication Critical patent/NO941073D0/en
Publication of NO941073L publication Critical patent/NO941073L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68—Halogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO941073A 1993-03-26 1994-03-24 Phenylglycinamide of heterocyclic substituted phenylacetic acid derivatives NO941073L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4309968A DE4309968A1 (en) 1993-03-26 1993-03-26 Phenylglycinamides of heterocyclic substituted phenylacetic acid derivatives

Publications (2)

Publication Number Publication Date
NO941073D0 true NO941073D0 (en) 1994-03-24
NO941073L NO941073L (en) 1994-09-27

Family

ID=6484001

Family Applications (1)

Application Number Title Priority Date Filing Date
NO941073A NO941073L (en) 1993-03-26 1994-03-24 Phenylglycinamide of heterocyclic substituted phenylacetic acid derivatives

Country Status (15)

Country Link
EP (1) EP0622358A1 (en)
JP (1) JPH06329637A (en)
KR (1) KR940021532A (en)
CN (1) CN1102645A (en)
AU (1) AU5788694A (en)
CA (1) CA2119669A1 (en)
CZ (1) CZ71094A3 (en)
DE (1) DE4309968A1 (en)
FI (1) FI941380A (en)
HU (1) HUT68514A (en)
IL (1) IL109093A0 (en)
NO (1) NO941073L (en)
NZ (1) NZ260163A (en)
SK (1) SK35094A3 (en)
ZA (1) ZA942119B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0839799A4 (en) * 1995-05-19 1998-07-29 Kissei Pharmaceutical 2-hydroxyphenylalkylamine derivatives and maillard reaction inhibitors
DE19613550A1 (en) * 1996-04-04 1997-10-09 Bayer Ag New pyrimido [1,2-a] indoles
EP0802192A1 (en) * 1996-04-17 1997-10-22 Bayer Ag Heterocyclic-substituted phenylglycinolamides with antiatheroschlerotic activity and process for their production
DE19619950A1 (en) 1996-04-17 1997-10-23 Bayer Ag Heterocyclic substituted phenylglycinolamides
DE19615265A1 (en) * 1996-04-18 1997-12-04 Bayer Ag New pyridazino, pyrimido, pyrazino and triazinoindoles
EP1013273A1 (en) * 1998-12-23 2000-06-28 Novartis AG Use of AT-1 receptor antagonist or AT-2 receptor modulator for treating diseases associated with an increase of AT-1 or AT-2 receptors
NZ587909A (en) * 1998-12-23 2012-05-25 Novartis Ag Process of making a compressed tablets containing valsartan and microcrystalline cellulose

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4200954A1 (en) * 1991-04-26 1992-10-29 Bayer Ag New heterocycle-substd. phenylacetic acid derivs. - are angiotensin II antagonists for treating arterial hypertonia, atherosclerosis, coronary insufficiency, ischaemic cerebral disorders, respiratory disorders, etc.
DE4208051A1 (en) * 1992-03-13 1993-09-16 Bayer Ag SUBSTITUTED PHENYL ACIDIC ACID AMIDE

Also Published As

Publication number Publication date
EP0622358A1 (en) 1994-11-02
FI941380A (en) 1994-09-27
ZA942119B (en) 1994-11-07
HUT68514A (en) 1995-06-28
HU9400865D0 (en) 1994-06-28
CZ71094A3 (en) 1994-10-19
CN1102645A (en) 1995-05-17
DE4309968A1 (en) 1994-09-29
CA2119669A1 (en) 1994-09-27
NZ260163A (en) 1996-02-27
FI941380A0 (en) 1994-03-24
KR940021532A (en) 1994-10-19
IL109093A0 (en) 1994-06-24
JPH06329637A (en) 1994-11-29
SK35094A3 (en) 1995-10-11
NO941073L (en) 1994-09-27
AU5788694A (en) 1994-09-29

Similar Documents

Publication Publication Date Title
BR9510256A (en) Derivatives of 3-aryl-tetronic acid
ATE211131T1 (en) ARYLSULFONYLAMINOHYDROXAMIC ACID DERIVATIVES
NO983940D0 (en) Derivatives of substituted 4-hydroxyphenylalcanoic acid with agostic activity for ppargamma
FI944800A (en) Indole-2-carboxylic acid derivatives
DE69703385T2 (en) ALCOXYACETIC ACID DERIVATIVES
ATE257836T1 (en) SALT OF NAPHTHYRIDINCARBOXIC ACID DERIVATIVES
EE9500059A (en) Use of substituted 4-phenyl-6-aminonicotinic acid derivatives as medicaments
AU3150289A (en) Heterocyclic substituted dihaloisonicotinic acid amide derivatives
FI955164A0 (en) Heterocyclic derivatives
NO923580L (en) SUBSTITUTED IMIDAZOLYLPROPENIC ACID DERIVATIVES
FI970110A (en) Anti-Helicobacterial heterocyclic azolone derivatives
FI941712A (en) Heterocyclic iminobismethylene bisphosphonic acid derivatives
DE69718338D1 (en) 3-ALKOXYISOXAZOLE-4-YL-SUBSTITUTED 2-AMINOCARBONIC ACID DERIVATIVES
NO941073D0 (en) Phenylglycinamide of heterocyclic substituted phenylacetic acid derivatives
EE9700186A (en) Salts of clavulanic acid
FI941149A0 (en) Derivatives of 2,4-diamino-3-hydroxycarboxylic acid
DK0946548T3 (en) Novel heterocyclic substituted pyrrolidinamide derivatives
DE59606437D1 (en) 5-PYRAZOLYLBENZOIC ACID DERIVATIVES AS HERBICIDES
DE69502982D1 (en) Production of protected aminothiazolylacetic acid derivatives
NO20002154D0 (en) Novel heterocyclic substituted alpha hydroxycarboxylic acid derivatives
NO995841D0 (en) Process for the preparation of 3- (7-amidino-2-naphthyl) -2-phenylpropionic acid derivatives
FI940133A0 (en) New nicotinic acid derivatives
NO940131D0 (en) Salts of 4-pyrimidinone derivatives for framasoytic use
NO991098D0 (en) Process for the preparation of 2-phenyl-3-naphthylpropionic acid derivatives
DE633242T1 (en) Derivatives of heptanoic acid.